跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 11,925 条关于
“Hunter Capital”
全部
11,925
临床试验
7,177
药物
409
机构
869
资讯
3,470
去年
SynAct Pharma Secures SEK 30 Million Credit Facility to Advance Rheumatoid Arthritis Drug Development Through Mid-2026
4天前
ResoTher's Annexin A1 Mimetic RTP-026 Shows 8-Point LVEF Gain in Phase 2a STEMI Trial, Clearing Acquisition Hurdle
去年
Morphic Therapeutic's MORF-627 Fails to Reach Clinical Trials Due to Oncogenic Toxicity
8年前
PMV Pharma's Rezatapopt: First p53(Y220C) Stabilizer Shows Promise in Solid Tumors
去年
GC Biopharma's Hunterase ICV Approved in Russia for Severe Hunter Syndrome
6年前
Advancements in Neurology: From Hunter Syndrome to Alzheimer's Disease
去年
Drug Hunter Secures Seed Investment to Expand Knowledge Platform for Pharmaceutical R&D
去年
GC Biopharma's Hunterase Shows Significant Efficacy in Phase 3 Trial for Hunter Syndrome
上个月
Hunter Biden Reveals Former President Joe Biden's Prostate Cancer Has Metastasized to Bones
去年
Denali Therapeutics' Tividenofusp Alfa Receives FDA Breakthrough Therapy Designation for Hunter Syndrome
第 1 页,共 347 页
上一页
下一页